← Back to directory

Jacques Robert

Researcher Next ID · RN-032623

Researcher · Biochemistry, Genetics and Molecular Biology

Centre National de la Recherche Scientifique

Paris, France

Accepting doctoral researchersFunding unknown
Works count
1,164
Citation count
20,064
H-index
67
i10-index
387

Research interests

Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
Cancer Treatment and Pharmacology
Cancer therapeutics and mechanisms
Immune Cell Function and Interaction
T-cell and B-cell Immunology
Drug Transport and Resistance Mechanisms

Publications

  • CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics

    Nucleic Acids Research · 2020 · 10.1093/nar/gkaa968

  • Review of the Amphibian Immune Response to Chytridiomycosis, and Future Directions

    Frontiers in Immunology · 2018 · 10.3389/fimmu.2018.02536

  • Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies

    European Journal of Cancer · 2017 · 10.1016/j.ejca.2017.02.003

  • Genome evolution in the allotetraploid frog Xenopus laevis

    Nature · 2016 · https://doi.org/10.1038/nature19840

  • Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy

    Cancer Chemotherapy and Pharmacology · 2015 · 10.1007/s00280-015-2901-x

  • ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis

    Clinical Cancer Research · 2011 · 10.1158/1078-0432.ccr-10-2169

  • Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins

    Mammalian Genome · 2010 · https://doi.org/10.1007/s00335-010-9284-4

  • The Genome of the Western Clawed Frog Xenopus tropicalis

    Science · 2010 · https://doi.org/10.1126/science.1183670

  • Innate Immune Responses and Permissiveness to Ranavirus Infection of Peritoneal Leukocytes in the FrogXenopus laevis

    Journal of Virology · 2010 · 10.1128/jvi.02486-09

  • Comparative and developmental study of the immune system in Xenopus

    Developmental Dynamics · 2009 · 10.1002/dvdy.21891

  • Expression Profiling the Temperature-Dependent Amphibian Response to Infection by Batrachochytrium dendrobatidis

    PLoS ONE · 2009 · 10.1371/journal.pone.0008408

  • Development and characterization of a model system to study amphibian immune responses to iridoviruses

    Virology · 2003 · 10.1016/s0042-6822(03)00151-x

  • Evolution of heat shock protein and immunity

    Developmental & Comparative Immunology · 2003 · https://doi.org/10.1016/s0145-305x(02)00160-x

  • Correlation Between Uracil and Dihydrouracil Plasma Ratio, Fluorouracil (5-FU) Pharmacokinetic Parameters, and Tolerance in Patients With Advanced Colorectal Cancer: A Potential Interest for Predicting 5-FU Toxicity and Determining Optimal 5-FU Dosage

    Journal of Clinical Oncology · 1999 · https://doi.org/10.1200/jco.1999.17.4.1105

  • Identification of a New Metabolite of CPT-11 (Irinotecan): Pharmacological Properties and Activation to SN-38

    Journal of Pharmacology and Experimental Therapeutics · 1998 · 10.1016/s0022-3565(24)37620-7

  • Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.

    PubMed · 1998

  • Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.

    Journal of Clinical Oncology · 1998 · 10.1200/jco.1998.16.4.1470

  • Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.

    PubMed · 1997

  • Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients.

    PubMed · 1996

  • Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase

    Biochemical Pharmacology · 1996 · 10.1016/0006-2952(96)00457-1

  • Identification and kinetics of a ?-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan

    Cancer Chemotherapy and Pharmacology · 1995 · 10.1007/bf00689205

  • Standardization of the rainflow counting method for fatigue analysis

    International Journal of Fatigue · 1994 · https://doi.org/10.1016/0142-1123(94)90343-3

  • Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture

    European Journal of Cancer · 1994 · 10.1016/s0959-8049(05)80025-5

  • Pharmacokinetics and metabolism of anthracyclines.

    PubMed · 1993

  • Right ventricular overload and induced sustained ventricular tachycardia in operatively “repaired” tetralogy of Fallot

    The American Journal of Cardiology · 1992 · 10.1016/0002-9149(92)90506-t

  • Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis

    Journal of Allergy and Clinical Immunology · 1991 · https://doi.org/10.1016/0091-6749(91)90213-8

  • Age‐related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population

    American Journal of Medical Genetics · 1989 · https://doi.org/10.1002/ajmg.1320320302

Current projects

    No projects listed.